Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome
This study has been completed.
Study NCT00077116
Information provided by European Organisation for Research and Treatment of Cancer - EORTC
First Received on February 10, 2004.
Last Updated on July 13, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
